FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to a novel drug based on anti-cholinergic agents and inhibitors of EGFR kinase, capsules containing inhalation powder and to using a drug designated for treatment of inflammatory and obstructive diseases of respiratory ways. Invention describes a novel medicinal agent useful in using in diseases of respiratory ways.
EFFECT: valuable medicinal and biochemical properties of compositions.
32 cl, 1 dwg, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INHALER | 2008 |
|
RU2480248C2 |
| NOZZLE AND INHALER AND METHOD OF NOZZLE FABRICATION | 2009 |
|
RU2495726C2 |
| OPTICAL CONTROL OF FILLING OF PHARMACEUTICAL CAPSULES ON CAPSULE-FILLING MACHINES | 2008 |
|
RU2475727C2 |
| POWDER INHALATOR | 2005 |
|
RU2369411C2 |
| INHALER | 2008 |
|
RU2470680C2 |
| NEW ANTICHOLINERGIC PREPARATIONS, METHOD OF THEIR PRODUCTION AND THEIR APPLICATION AS PHARMACEUTICALS | 2003 |
|
RU2325388C2 |
| INHALER | 2015 |
|
RU2655131C2 |
| NEW ENANTIOMER-FREE β-AGONISTS, THEIR PREPARATION METHOD AND THEIR APPLICATION IN CAPACITY OF MEDICATIONS | 2005 |
|
RU2378262C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES MEDIATED BY CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | 2015 |
|
RU2744460C2 |
| CERTAIN CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS | 2014 |
|
RU2718876C2 |
